Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-5-1
pubmed:databankReference
pubmed:abstractText
Tumor necrosis factor-alpha is present in arteries in giant cell arteritis.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1539-3704
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
146
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
621-30
pubmed:dateRevised
2008-1-31
pubmed:meshHeading
pubmed-meshheading:17470830-Aged, pubmed-meshheading:17470830-Anti-Inflammatory Agents, pubmed-meshheading:17470830-Antibodies, Monoclonal, pubmed-meshheading:17470830-Blood Sedimentation, pubmed-meshheading:17470830-C-Reactive Protein, pubmed-meshheading:17470830-Double-Blind Method, pubmed-meshheading:17470830-Drug Therapy, Combination, pubmed-meshheading:17470830-Female, pubmed-meshheading:17470830-Giant Cell Arteritis, pubmed-meshheading:17470830-Glucocorticoids, pubmed-meshheading:17470830-Humans, pubmed-meshheading:17470830-Interleukin-6, pubmed-meshheading:17470830-Male, pubmed-meshheading:17470830-Prednisolone, pubmed-meshheading:17470830-Prednisone, pubmed-meshheading:17470830-Recurrence, pubmed-meshheading:17470830-Remission Induction, pubmed-meshheading:17470830-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
pubmed:affiliation
Center for Vasculitis Care and Research, The Cleveland Clinic Foundation, Lerner College of Medicine, Cleveland, Ohio 44195, USA.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural